Serveur d'exploration Tocilizumab - Analysis (France)

Index « Keywords » - entrée « Middle Aged »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Microenvironment < Middle Aged < Molecular Targeted Therapy  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 104.
[40-60] [0 - 20][0 - 50][60-80]
Ident.Authors (with country if any)Title
000298 (2016) A. Deroux [France] ; F. Andry [France] ; L. Bouillet [France][Macrophage activation syndrome secondary to tocilizumab: Myth or reality?].
000299 (2016) C. Boin [France] ; S. Lambert [France] ; P. Thomann [France] ; O. Aujoulat [France] ; P. Kieffer [France][Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
000300 (2016) X. Palard-Novello [France] ; S. Querellou [France] ; M. Gouillou [France] ; A. Saraux [France] ; T. Marhadour [France] ; F. Garrigues [France] ; R. Abgral [France] ; P Y Salaün [France] ; V. Devauchelle-Pensec [France]Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
000307 (2016) B. Clarivet [France] ; P. Robin [France] ; Y M Pers [France] ; R. Ferreira [France] ; J. Lebrun [France] ; C. Jorgensen [France] ; D. Hillaire-Buys [France] ; V. Brés [France] ; J L Faillie [France]Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein.
000314 (2016) Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Angelika Jahreis [États-Unis] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Janet E. Pope [Canada] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Robert Lafyatis [États-Unis] ; Giuseppina Stifano [États-Unis] ; Helen Spotswood [Royaume-Uni] ; Haiyin Chen-Harris [États-Unis] ; Sebastian Dziadek [Suisse] ; Alyssa Morimoto [États-Unis] ; Thierry Sornasse [États-Unis] ; Jeffrey Siegel [États-Unis] ; Daniel E. Furst [États-Unis]Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
000315 (2016) Louise K. Mercer [Royaume-Uni] ; Johan Askling [Suède] ; Pauline Raaschou [Suède] ; William G. Dixon [Royaume-Uni] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Xavier Mariette [France] ; Axel Finckh [Suisse] ; Helena Canhao [Portugal] ; Florenzo Iannone [Italie] ; Jakub Zavada [République tchèque] ; Jacques Morel [France] ; Jacques-Eric Gottenberg [France] ; Kimme L. Hyrich [Royaume-Uni] ; Joachim Listing [Allemagne]Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
000319 (2016) Éric Toussirot [France] ; Antoine Martin [France] ; Martin Soubrier [France] ; Serge Redeker [France] ; Alexis Régent [France]Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
000321 (2016) P O Barros ; T. Cassano ; J. Hygino ; T B Ferreira ; N. Centurião ; T M Kasahara ; R M Andrade ; U C Linhares ; A F B. Andrade [Brésil] ; C C F. Vasconcelos ; R. Alvarenga ; R. Marignier [France] ; C A M. BentoPrediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
000327 (2016) Cindy Mourgues [France] ; Cecile Henquell [France] ; Zuzana Tatar [France] ; Bruno Pereira [France] ; Cinthya Nourisson [France] ; Anne Tournadre [France] ; Martin Soubrier [France] ; Marion Couderc [France]Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
000332 (2016) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
000338 (2016) Valérie Devauchelle-Pensec [France] ; Jean Marie Berthelot [France] ; Divi Cornec [France] ; Yves Renaudineau [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Solène Querellou [France] ; Florent Garrigues [France] ; Michel De Bandt [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
000340 (2016) Marie Fechtenbaum [France] ; Pauline Lasselin-Boyard ; Sarah Salomon ; Germain Jelin ; Florence Millot ; Franck Grados ; Patrice Fardellone ; Vincent GoëbDecrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot Study.
000345 (2016) A. Gardette [France] ; S. Ottaviani [France] ; J. Sellam [France] ; F. Berenbaum [France] ; F. Lioté [France] ; A. Meyer [France] ; J. Sibilia [France] ; B. Fautrel [France] ; E. Palazzo [France] ; P. Dieudé [France]Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
000351 (2016) C. Giraud [France] ; Z. Tatar [France] ; M. Soubrier [France]Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
000357 (2016) Stanislas Faguer [France] ; François Vergez [France] ; Michael Peres [France] ; Inès Ferrandiz [France] ; Audrey Casemayou [France] ; Julie Belliere [France] ; Olivier Cointault [France] ; Laurence Lavayssiere [France] ; Marie-Béatrice Nogier [France] ; Grégoire Prevot [France] ; Antoine Huart [France] ; Christian Recher [France] ; Lionel Rostaing [France]Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T‐cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis
000358 (2016) Janet S. Lee [États-Unis] ; M. John Chapman [France] ; Paolo Piraino [Italie] ; Jens Lamerz [Suisse] ; Thomas Schindler [Suisse] ; Paul Cutler [Suisse] ; Gregor Dernick [Suisse]Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab
000363 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000375 (2015) Clémentine Fortunet [France] ; Yves-Marie Pers [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Elodie Constant [France] ; Hervé Devilliers [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Jean Francis Maillefert [France]Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
000377 (2015) Aurelien Justet [France] ; Sebastien Ottaviani [France] ; Philippe Dieudé [France] ; Camille Taillé [France]Tocilizumab for refractory organising pneumonia associated with Sjögren's disease
000379 (2015) Karine Briot [France] ; Stéphanie Rouanet [France] ; Thierry Schaeverbeke [France] ; Fabien Etchepare [France] ; Philippe Gaudin [France] ; Aleth Perdriger [France] ; Muriel Vray [France] ; Ghislaine Steinberg [France] ; Christian Roux [France]The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis.
000383 (2015) Yves-Marie Pers [France] ; Marie Godfrin-Valnet ; Joseph Lambert ; Clémentine Fortunet ; Elodie Constant ; Thibault Mura ; Béatrice Pallot-Prades ; Christian Jorgensen ; Jean-Francis Maillefert ; Hubert Marotte ; Daniel Wendling ; Philippe GaudinResponse to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Middle Aged" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Middle Aged" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Middle Aged
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021